Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04526158 · ClinicalTrials.gov registry record · NA
Learning to Apply Mindfulness to Pain
A NA study, sponsored by United States Department of Defense.
- Completed
- Registry status
- NA
- Development phase
- 811
- Enrollment target
NCT04526158: Completed NA study, sponsored by United States Department of Defense.
NCT04526158 is a NA study that has completed, run by United States Department of Defense. The registered enrollment target is 811 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04526158, a NA study, has completed, sponsored by United States Department of Defense.
- COMPLETED
- Registry status
- NA
- Development phase
- 811 participants
- Enrollment target
Study Summary
The long-term goal of this two-phase project is to reduce chronic pain and co-morbid conditions among Veterans, through scalable, non-pharmacologic evidence-based strategies that are "Veteran-Centric," designed to optimize engagement, adherence and sustainability, and are deliverable to large numbers of Veterans.
Primary Outcome
Change in the Brief Pain Inventory (BPI) interference score. Minimum value: 0. Maximum value: 10. Higher scores indicate worse functioning. Change in the outcome measure operationalized as the weighted average of all of the time points during follow-up, adjusting for the baseline value prior to randomization.
Interventions
- BEHAVIORAL Mobile+Group LAMP Mindfulness-Based Intervention
- BEHAVIORAL Mobile LAMP Mindfulness-Based Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 811 participants |
| Start Date | 2020-11-02 |
| Est. Completion | 2023-12-30 |
| Phase | NA |
What the finished NCT04526158 record still lists
NCT04526158 is an interventional study that assigns participants to a tested intervention. The registered 811 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower).
The record links to 0 conditions, and to 2 interventions - of which Mobile+Group LAMP Mindfulness-Based Intervention is the first listed.
NCT04526158 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04526158 about?
NCT04526158 is a clinical study titled "Learning to Apply Mindfulness to Pain". The long-term goal of this two-phase project is to reduce chronic pain and co-morbid conditions among Veterans, through scalable, non-pharmacologic evidence-based strategies that are "Veteran-Centric," designed to optimize engagement, adherence and sustainability, and are deliverable to large number...
What is the current status of trial NCT04526158?
This trial is currently completed. It is a NA study. The enrollment target is 811 participants. The study started on 2020-11-02. Estimated completion is 2023-12-30.
What interventions are being tested in trial NCT04526158?
The interventions under investigation include: Mobile+Group LAMP Mindfulness-Based Intervention (BEHAVIORAL), Mobile LAMP Mindfulness-Based Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04526158?
This trial is sponsored by United States Department of Defense, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04526158's enrollment target sits among peer trials
811 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05519085 · 810 participants · Phase 3
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
- NCT06529094 · 808 participants · NA
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
- NCT07218029 · 815 participants · Phase 3
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI